Bridgefront Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,780
Closed -$393K 615
2024
Q3
$393K Sell
1,780
-667
-27% -$138K 0.15% 252
2024
Q2
$481K Buy
+2,447
New +$506K 0.2% 171
2022
Q3
Sell
-2,194
Closed -$449K 329
2022
Q2
$449K Buy
2,194
+437
+25% +$92.6K 0.5% 50
2022
Q1
$418K Buy
+1,757
New +$413K 0.51% 50
2021
Q4
Sell
-1,320
Closed -$255K 324
2021
Q3
$255K Sell
1,320
-3,244
-71% -$657K 0.27% 180
2021
Q2
$971K Buy
+4,564
New +$964K 0.37% 54
2021
Q1
Sell
-1,512
Closed -$275K 711
2020
Q4
$275K Buy
+1,512
New +$257K 0.09% 403

Other funds holding CME

Bridgefront Capital's CME Position: Q4 2024 in Review

Bridgefront Capital sold out of CME Group (CME) in Q4 2024, closing a stake of 1,780 shares — an estimated $393K sold.

Bridgefront Capital first reported a position in CME in Q4 2020 and held it in 7 quarters. The position peaked at $971K in Q2 2021. 1,500 funds tracked by Wall St. Rank hold CME as of Q4 2024.

  • Bridgefront Capital reported no remaining CME Group position as of Q4 2024 after selling out during the quarter.
  • Bridgefront Capital sold 1,780 CME Group shares in Q4 2024, an estimated $393K.
  • Bridgefront Capital first reported a position in CME Group in Q4 2020 and held it in 7 quarters.
  • Bridgefront Capital's CME Group position peaked at $971K in Q2 2021.
  • 1,500 funds tracked by Wall St. Rank held CME Group as of Q4 2024.

Based on Bridgefront Capital's 13F filing for Q4 2024, filed 14 Feb 2025.